Market Tracker

08/29 3:07am ET

Corcept Therapeutics Inc (NASDAQ:CORT)

5.50
Delayed Data
As of Aug 26
 +0.05 / +0.92%
Today’s Change
3.22
Today|||52-Week Range
6.33
+10.44%
Year-to-Date
Novartis (NVS) Reports Positive Phase III Results on MS Drug
Aug 26 / Zacks.com - Paid Partner Content
Gilead (GILD) Truvada Gets EU Approval for Label Expansion
Aug 23 / Zacks.com - Paid Partner Content
Mallinckrodt to Divest Nuclear Imaging Business for $690M
Aug 25 / Zacks.com - Paid Partner Content
Roche Launches Accu-Chek Blood Glucose Monitoring System
Aug 23 / Zacks.com - Paid Partner Content
Cempra's Application for Pneumonia Drug Validated in EU
Aug 24 / Zacks.com - Paid Partner Content
Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
Aug 22 / Zacks.com - Paid Partner Content
J&J (JNJ) Seeks EU Approval for Darzalex's Expanded Use
Aug 24 / Zacks.com - Paid Partner Content
What Falling Estimates & Price Mean for Merus Labs International (MSLI)
Aug 22 / Zacks.com - Paid Partner Content
Novartis Licenses Anti-PCSK9 Antibody to Cyon Therapeutics
Aug 24 / Zacks.com - Paid Partner Content
Insys Therapeutics Starts Enrollment in Cannabidiol Trial
Aug 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close5.45
Today’s open5.44
Day’s range5.37 - 5.55
Volume120,082
Average volume (3 months)331,062
Market cap$608.3M
Dividend yield--
Data as of 4:00pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+80.65%
Earnings growth (this year)+129.17%
Earnings growth (next 5 years)+49.29%
Revenue growth (last year)+89.39%
P/E ratio550.0
Price/Sales10.59
Price/Book32.60

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...-0.03-0.63%
RPTPRaptor Pharmaceutica...+0.25+3.56%
AIMTAimmune Therapeutics...+0.15+1.03%
DVAXDynavax Technologies...+0.17+1.06%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)$0.01
Annual revenue (last year)$50.3M
Annual profit (last year)-$6.4M
Net profit margin-12.74%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer, Director &
MD
Joseph K. Belanoff
Secretary &
Chief Financial Officer
Gary Charles Robb
Corporate headquarters
Menlo Park, California

Forecasts